Atrial fibrillation and stroke. A review on the use of vitamin K antagonists and novel oral anticoagulants
Atrial fibrillation (AF) is the most common arrhythmia, ranging from 0.1% in patients< 55
years to> 9% in octogenarian patients. One important issue is represented by the 5-fold …
years to> 9% in octogenarian patients. One important issue is represented by the 5-fold …
Cognitive function and atrial fibrillation: from the strength of relationship to the dark side of prevention. Is there a contribution from sinus rhythm restoration and …
E Gallinoro, S D'Elia, D Prozzo, M Lioncino, F Natale… - Medicina, 2019 - mdpi.com
Atrial fibrillation (AF) is the most common chronic cardiac arrhythmia with an increasing
prevalence over time mainly because of population aging. It is well established that the …
prevalence over time mainly because of population aging. It is well established that the …
Diagnosis and management of left atrium appendage thrombosis in atrial fibrillation patients undergoing cardioversion
E Melillo, G Palmiero, A Ferro, PE Mocavero, V Monda… - Medicina, 2019 - mdpi.com
Atrial fibrillation is the most common cardiac arrhythmia and is associated with an increased
risk of stroke and thromboembolic complications. A rhythm control strategy with both …
risk of stroke and thromboembolic complications. A rhythm control strategy with both …
Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence
V Russo, A Rago, R Proietti, F Di Meo… - … Advances in Drug …, 2017 - journals.sagepub.com
The aim of our article is to provide a concise review for clinicians entailing the main studies
that evaluated the efficacy and safety of target-specific oral anticoagulants (TSOAs) for …
that evaluated the efficacy and safety of target-specific oral anticoagulants (TSOAs) for …
Use of non–vitamin K antagonist oral anticoagulants in atrial fibrillation patients with malignancy: clinical practice experience in a single institution and literature …
V Russo, A Rago, AA Papa, F Di Meo… - … in Thrombosis and …, 2018 - thieme-connect.com
This observational study aimed to investigate the efficacy and safety of non–vitamin K
antagonist oral anticoagulants (NOACs) in atrial fibrillation (AF) patients with malignancy. A …
antagonist oral anticoagulants (NOACs) in atrial fibrillation (AF) patients with malignancy. A …
Nonvitamin K antagonist oral anticoagulants use in patients with atrial fibrillation and bioprosthetic heart valves/prior surgical valve repair: a multicenter clinical …
V Russo, E Attena, C Mazzone… - … in thrombosis and …, 2018 - thieme-connect.com
This is an observational study to investigate the efficacy and safety of nonvitamin K
antagonist oral anticoagulants (NOACs) in atrial fibrillation (AF) patients with bioprosthetic …
antagonist oral anticoagulants (NOACs) in atrial fibrillation (AF) patients with bioprosthetic …
Gender differences in atrial fibrillation: from the thromboembolic risk to the anticoagulant treatment response
A Rago, C Pirozzi, A D'Andrea, P Di Micco, AA Papa… - Medicina, 2023 - mdpi.com
Atrial fibrillation (AF) is the most common cardiac arrhythmia associated with an increased
thromboembolic risk. The impact of the female sex as an independent risk factor for …
thromboembolic risk. The impact of the female sex as an independent risk factor for …
Efficacy and safety of dabigatran in patients with atrial fibrillation scheduled for transoesophageal echocardiogram-guided direct electrical current cardioversion: a …
V Russo, A Rago, AA Papa, A D'Onofrio… - Journal of Thrombosis …, 2018 - Springer
Patients with atrial fibrillation (AF) are predisposed to a hypercoagulable state and are at an
increased risk for thromboembolic events when undergoing procedures. This study …
increased risk for thromboembolic events when undergoing procedures. This study …
Clinical performance of apixaban vs. vitamin K antagonists in patients with atrial fibrillation undergoing direct electrical current cardioversion: a prospective propensity …
A Rago, AA Papa, A Cassese, G Arena… - American Journal of …, 2019 - Springer
Introduction Atrial fibrillation (AF) is associated with an increased risk of thromboembolic
events. Objectives This study compared the long-term efficacy and safety of apixaban with …
events. Objectives This study compared the long-term efficacy and safety of apixaban with …
The CHA2DS2-VASc Score Predicts Major Bleeding in Non-Valvular Atrial Fibrillation Patients Who Take Oral Anticoagulants
KT Lee, SH Chang, YH Yeh, HT Tu, YH Chan… - Journal of clinical …, 2018 - mdpi.com
Background: Patients with atrial fibrillation (AF) are at a substantial risk of ischemic stroke.
The CHA2DS2-VASc score predicts the risk of thromboembolism, but its role in predicting …
The CHA2DS2-VASc score predicts the risk of thromboembolism, but its role in predicting …